Stay updated on Venetoclax and Novel Agents in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.

Latest updates to the Venetoclax and Novel Agents in AML Clinical Trial page
- Check7 days agoChange DetectedThe footer’s ClinicalTrials.gov software revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check14 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check21 days agoChange DetectedThe record now shows a study-status update submitted on September 30 and posted October 5, replacing the prior June 8 update date.SummaryDifference0.3%

- Check35 days agoChange DetectedAn added UI label 'Find contact information' appears in the history, and the revision note updates to v3.7.0. These changes are minor UI/text and versioning adjustments rather than substantive alterations to the study data or core content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now shows Revision: v3.6.6, indicating a new version of the record. This appears to be a maintenance/update to metadata rather than substantive changes to the study information.SummaryDifference0.1%

- Check78 days agoChange DetectedThe version history now shows a new revision entry (v3.6.5) added to the study record. The prior revision (v3.6.4) has been removed, indicating a page version update.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Novel Agents in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.